Posts by John

Discover how AI and machine learning are revolutionizing clinical trial statistics, reducing development costs, and improving data accuracy in drug research.

Discover why healthcare AI devices are facing increased recalls. Learn about data drift, algorithm transparency, and FDA safety standards in our latest report.

Eli Lilly’s investment in Abridge highlights a critical, often ignored gap in clinical trial recruitment. Learn why the “handoff” is failing patients.

Researchers successfully delivered dopamine-producing gene therapy to the brain. Discover the clinical hurdles ahead for this Parkinson’s breakthrough.

New trial data shows atumelnant reduces androgen levels by 67% in CAH patients, offering a potential breakthrough to lower glucocorticoid dependency.

A study shows the Selinexor-Ruxolitinib combination meets primary endpoints for myelofibrosis, offering a new hope for patients failing JAK inhibitors.

New trial data confirms pirtobrutinib slashes CLL progression risk by 45%. Explore the clinical impact of this breakthrough BTK inhibitor for oncology.

Explore the projected growth of the decentralized clinical trials market through 2034 and how digital health tech is transforming global drug development.

Discover how the synergy between AI technology and clinical expertise is revolutionizing patient matching for cancer trials and accelerating research.

The FDA has cleared the first OTC continuous glucose monitor for children, improving access to real-time diabetes tracking and pediatric glycemic management.